Delivery Order SPE2DB20D1110-SPE2DB25FK04L
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $62,107.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to supply DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a completion date of May 14, 2024. The contract has a Firm Fixed Price pricing type and was not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,715.72 Firm Fixed Price Delivery Order contract is for the supply of DAPAGLIFLOZIN 10 MG TABLETs. The contract has a period of performance through July 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,006.48 Firm Fixed Price Delivery Order contract is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $7,063.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a performance period extending to February 25, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,779.15, is a Firm Fixed Price Delivery Order for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S. The award has an ultimate completion date of May 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,539.39, is a delivery order for the supply of 4567957850 DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication. The contract is not set aside and is a firm fixed-price agreement with an ultimate completion date of April 18, 2025. Additionally, AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $28,482.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of dapagliflozin 10 mg tablets. The contract is a firm fixed-price delivery order that runs through December 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,741.99, is a delivery order for the supply of Dapagliflozin 10 mg tablets. It has a firm fixed price and an ultimate completion date of August 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $19,543.78, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566348598 - Dapagliflozin 10 mg Tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,206.30, is a delivery order for the provision of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 14, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...